Greg Oehrtman

Title: The Innovative Contributions of Greg Oehrtman

Introduction

Greg Oehrtman is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release formulations. His work focuses on improving patient compliance through innovative drug delivery systems.

Latest Patents

Oehrtman holds a patent for "Sustained release formulations using non-aqueous carriers." This patent describes one-component, injectable, sustained release formulations that comprise microspheres containing active pharmaceutical ingredients, such as exenatide. The microspheres are suspended in a non-aqueous carrier, which can include oils, triglycerides, and other similar substances. These formulations offer distinct advantages, including a long shelf life for stability and potency, as well as a sustained release of active ingredients to reduce the frequency of medication dosing.

Career Highlights

Throughout his career, Greg Oehrtman has worked with prominent companies in the pharmaceutical industry. He has been associated with Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Oehrtman has collaborated with several professionals in his field, including Mary L. Houchin and Robin Lee. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Greg Oehrtman's contributions to the field of pharmaceuticals through his innovative patent and career experiences highlight his commitment to improving patient care. His work continues to influence the development of effective drug delivery systems.